NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches
dc.contributor.author | Almodóvar-Payá, Carmen | |
dc.contributor.author | Guardiola-Ripoll, Maria | |
dc.contributor.author | Giralt-López, Maria | |
dc.contributor.author | Gallego, Carme | |
dc.contributor.author | Salgado-Pineda, Pilar | |
dc.contributor.author | Miret, Salvador | |
dc.contributor.author | Salvador, Raymond | |
dc.contributor.author | Muñoz, María J. | |
dc.contributor.author | Lázaro, Luisa | |
dc.contributor.author | Guerrero-Pedraza, Amalia | |
dc.contributor.author | Parellada, Mara | |
dc.contributor.author | Carrión, María I. | |
dc.contributor.author | Cuesta, Manuel J. | |
dc.contributor.author | Maristany, Teresa | |
dc.contributor.author | Sarró, Salvador | |
dc.contributor.author | Fañanás, Lourdes | |
dc.contributor.author | Callado Hernando, Luis Felipe | |
dc.contributor.author | Arias, Bárbara | |
dc.contributor.author | Pomarol-Clotet, Edith | |
dc.contributor.author | Fatjó-Vilas, Mar | |
dc.date.accessioned | 2022-08-10T07:54:00Z | |
dc.date.available | 2022-08-10T07:54:00Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | International Journal of Molecular Sciences 23(13) : (2022) // Article ID 7456 | es_ES |
dc.identifier.issn | 1422-0067 | |
dc.identifier.uri | http://hdl.handle.net/10810/57279 | |
dc.description.abstract | Included in the neurotrophins family, the Neuritin 1 gene (NRN1) has emerged as an attractive candidate gene for schizophrenia (SZ) since it has been associated with the risk for the disorder and general cognitive performance. In this work, we aimed to further investigate the association of NRN1 with SZ by exploring its role on age at onset and its brain activity correlates. First, we developed two genetic association analyses using a family-based sample (80 early-onset (EO) trios (offspring onset ≤ 18 years) and 71 adult-onset (AO) trios) and an independent case–control sample (120 healthy subjects (HS), 87 EO and 138 AO patients). Second, we explored the effect of NRN1 on brain activity during a working memory task (N-back task; 39 HS, 39 EO and 39 AO; matched by age, sex and estimated IQ). Different haplotypes encompassing the same three Single Nucleotide Polymorphisms(SNPs, rs3763180–rs10484320–rs4960155) were associated with EO in the two samples (GCT, TCC and GTT). Besides, the GTT haplotype was associated with worse N-back task performance in EO and was linked to an inefficient dorsolateral prefrontal cortex activity in subjects with EO compared to HS. Our results show convergent evidence on the NRN1 association with EO both from genetic and neuroimaging approaches, highlighting the role of neurotrophins in the pathophysiology of SZ. | es_ES |
dc.description.sponsorship | This study received funding provided by: (i) Fundación Alicia Koplowitz; (ii) Acadèmia de les Ciències Mèdiques i de la Salut de Catalunya i de Balears (predoctoral contract to C.A.-P.); (iii) the Instituto de Salud Carlos III through a PFIS predoctoral contract to M.G.-R. (FI19/0352) and a Miguel Servet contract to M.F.-V. (CP20/00072), co-funded by European Regional Development Fund (ERDF)/European Social Fund “Investing in your future”; (iv) the Comissionat per a Universitats i Recerca del DIUE of the Generalitat de Catalunya (Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), 2017SGR1271 and 2017SGR1577). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | schizophrenia-spectrum disorders | es_ES |
dc.subject | NRN1 | es_ES |
dc.subject | age at onset | es_ES |
dc.subject | working memory | es_ES |
dc.subject | functional magnetic resonance imaging (fMRI) | es_ES |
dc.title | NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.date.updated | 2022-07-08T11:55:46Z | |
dc.rights.holder | © 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). | es_ES |
dc.relation.publisherversion | https://www.mdpi.com/1422-0067/23/13/7456 | es_ES |
dc.identifier.doi | 10.3390/ijms23137456 | |
dc.departamentoes | Farmacología | |
dc.departamentoeu | Farmakologia |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as © 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).